Cannabidiol Ameliorates Doxorubicin-Induced Myocardial Injury via Activating Hippo Pathway

Cannabidiol Ameliorates Doxorubicin-Induced Myocardial Injury via Activating Hippo Pathway

Tianwei Dong,1 Jinlian Li,2 Xinfang Liang,3 Wang Wang,3 Meichi Chen,4 Guangyuan Yang,5 Dongmei Wu4 1Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, 154000, People’s Republic of China; 2College of Phar...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dong T, Li J, Liang X, Wang W, Chen M, Yang G, Wu D
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-01-01
Series:	Drug Design, Development and Therapy
Subjects:	doxorubicin heart injury cannabidiol hippo pathway
Online Access:	https://www.dovepress.com/cannabidiol-ameliorates-doxorubicin-induced-myocardial-injury-via-acti-peer-reviewed-fulltext-article-DDDT
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Hippo pathway promotes platinum-based chemotherapy by inhibiting MTF1-dependent heavy metal response
by: Hui Chen, et al.
Published: (2025-02-01)

Regulation of Hippo-YAP1/TAZ pathway in metabolic dysfunction-associated steatotic liver disease
by: Wei Xuan, et al.
Published: (2025-01-01)

Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
by: Li Chen, et al.
Published: (2025-01-01)

Exploring the Therapeutic Potential of Cannabidiol in U87MG Cells: Effects on Autophagy and NRF2 Pathway
by: Laura Giannotti, et al.
Published: (2024-12-01)

METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling
by: Mei Pu, et al.
Published: (2025-01-01)

Porphyra haitanensis polysaccharide (PH) attenuates cell hyperplasia via remodeling the cross-talk between Hippo/YAP and mTOR pathways
by: Chong Wang, et al.
Published: (2023-03-01)

Potential cytotoxic effect of cannabidiol against human glioblastoma cells in vitro
by: Justyna Lasota, et al.
Published: (2024-09-01)

Cannabidiol Modulates Neuroinflammatory and Estrogen-Related Pathways in a Sex-Specific Manner in a Chronic Stress Model of Depression
by: Uri Bright, et al.
Published: (2025-01-01)

Patterns of cannabidiol use among marijuana users in the United States
by: Ji-Yeun Park
Published: (2025-02-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

Effect of sacubitril/valsartan on inflammation and oxidative stress in doxorubicin-induced heart failure model in rabbits
by: Yu Chun, et al.
Published: (2021-09-01)

Novel Intravenous Nanoemulsions Based on Cannabidiol-Enriched Hemp Oil—Development and Validation of an HPLC-DAD Method for Cannabidiol Determination
by: Agnieszka Sobczak, et al.
Published: (2025-01-01)

Streptomyces-derived nano-doxorubicin: Clinical status and patents granted
by: Kaur Prabhjot, et al.
Published: (2024-01-01)

Exploring the effects of cannabidiol encapsulation in liposomes on their physicochemical properties and biocompatibility
by: Inga Jurgelane, et al.
Published: (2025-12-01)

Cannabidiol attenuates lipid metabolism and induces CB1 receptor-mediated ER stress associated apoptosis in ovarian cancer cells
by: Xuanhe Fu, et al.
Published: (2025-02-01)

Analysis of doxorubicin and fullerenol in rat serum by micellar electrokinetic capillary chromatography
by: Injac Rade, et al.
Published: (2024-09-01)

miR-301a-mediated crosstalk between the Hedgehog and HIPPO/YAP signaling pathways promotes pancreatic cancer
by: Bing Qi, et al.
Published: (2025-12-01)

Glutamate enhances shrimp antibacterial ability by boosting its cellular immunity
by: Lei Ma, et al.
Published: (2025-06-01)

Determination of protective effectiveness of nerium oleander distillation in doxorubicin-induced organ damages
by: Burak Dik, et al.

Selection of In Vivo Relevant Dissolution Test Parameters for the Development of Cannabidiol Formulations with Enhanced Oral Bioavailability
by: Nathan Koch, et al.
Published: (2025-01-01)

m6A Reader PRRC2A Promotes Colorectal Cancer Progression via CK1ε‐Mediated Activation of WNT and YAP Signaling Pathways
by: Xi Wu, et al.
Published: (2025-01-01)

Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments
by: Bowen Yin, et al.
Published: (2025-01-01)

Apelinergic System Affects Electrocardiographic Abnormalities Induced by Doxorubicin
by: Kasper Buczma, et al.
Published: (2025-01-01)

Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro
by: Windy Aristiani, et al.
Published: (2024-04-01)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
by: İlker Selçuk, et al.
Published: (2015-04-01)

Optimization of extraction and enrichment process of cannabidiol from industrial hemp and evaluation of its bioactivity
by: Junkai Wu, et al.
Published: (2025-02-01)

Unveiling cellular changes in leukaemia cell lines after cannabidiol treatment through lipidomics
by: David Chamoso-Sanchez, et al.
Published: (2025-01-01)

Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro
by: Rudolfová Petra, et al.
Published: (2014-06-01)

Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta‐9‐Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple Routes
by: Lixuan Qian, et al.
Published: (2025-01-01)

Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signaling pathway in breast cancer
by: Xiaoxia Jin, et al.
Published: (2019-03-01)

Shexiang Tongxin dropping pills ameliorate myocardial ischemia-reperfusion injury progression via the S1PR2/RhoA/ROCK pathway
by: Ying Sun, et al.
Published: (2025-01-01)

Doxorubicin-Conjugated Nanoparticles for Potential Use as Drug Delivery Systems
by: Alua Imantay, et al.
Published: (2025-01-01)

Exploring the Revolutionary Impact of YAP Pathways on Physical and Rehabilitation Medicine
by: Carmelo Pirri
Published: (2025-01-01)

A Review of Human Studies Assessing the Efficacy of Cannabidiol for Anxiety Disorders
by: Kuba Borys Romańczuk, et al.
Published: (2025-02-01)

The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment
by: Antonia Keck, et al.
Published: (2025-01-01)

The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity
by: Saba Dadpour, et al.
Published: (2022-09-01)

Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation
by: Ai-Li Xu, et al.
Published: (2025-01-01)

GV1001, hTERT Peptide Fragment, Prevents Doxorubicin-Induced Endothelial-to-Mesenchymal Transition in Human Endothelial Cells and Atherosclerosis in Mice
by: Wei Chen, et al.
Published: (2025-01-01)

Acute Myocardial Injury in Intracerebral Hemorrhage: Smoking Gun or Innocent Bystander
by: Regina von Rennenberg, et al.
Published: (2025-02-01)

Cannabidiol Vaping–Associated Multifocal NSCLC in a 24-Year-Old Female: A Case Report
by: Mansi Barthwal, MD, et al.
Published: (2025-03-01)